1 Breast Cancer Risk Prediction Bernard Rosner Impact of Time-Dependent Risk Factors and Heterogeneity by ER/PR Receptor Status.

Slides:



Advertisements
Similar presentations
1 Epidemiologic Measures of Association Saeed Akhtar, PhD Associate Professor, Epidemiology Division of Epidemiology and Biostatistics Aga Khan University,
Advertisements

Nutrition & Exercise During Pregnancy. Why is This Relevant to Me? Everyone knows someone who is pregnant/going to become pregnant Diet and Exercise are.
Serena T. Wong, MD Assistant Professor of Medicine
Childhood Obesity Landscape. Objectives for This Session  Define childhood obesity (CHO) and understand its scope and effects  Share who some of the.
Obesity at Diagnosis Is Associated with Inferior Outcomes in Hormone Receptor Positive Breast Cancer 1 The Impact of Body Mass Index (BMI) on the Efficacy.
Periodic Woman Screening Sheet By Periodic Woman Screening Committee January 2010.
Definitions Body Mass Index (BMI) describes relative weight for height: weight (kg)/height (m 2 ) Overweight = 25–29.9 BMI Obesity = >30 BMI.
The DASH Study Patrick Leonberger MSIV BGSMC Nov 8, 2013.
What women can do to stay healthy Valerie Beral University of Oxford THE MILLION WOMEN STUDY.
Intermediate methods in observational epidemiology 2008 Confounding - II.
Anthropometry and Breast Cancer Publication van den Brandt, P.A., et al. Pooled analysis of prospective cohort studies on height, weight and breast cancer.
Alcohol and Breast Cancer Publications Smith-Warner, S.A., et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA. 1998;
Hunter, D.J., et al. Cohort studies of fat intake and the risk of breast cancer -- a pooled analysis. New England Journal of Medicine. 1996; 334:
Assessment of Declining Health Status
BRCA1 and BRCA2 Mutations and Breast Cancer: An Integrated Approach Using Four Epidemiologic Parameters Monica McClain, PhD. Assistant Director, Biometry.
Breast cancer prevention
Physical Activity and Reduction of Breast Cancer Risk.
BMI: Body Mass Index. The term BMI is often used when discussing the obesity epidemic, but what is BMI?
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 12: Multiple and Logistic Regression Marshall University.
Are the results valid? Was the validity of the included studies appraised?
Tenth Anniversary of Initial Women’s Health Initiative (WHI) Report Richard Santen, MD University of Virginia 12/2/11.
Epidemiology of Breast Cancer Selected Highlights Jack Cuzick, Ph.D Cancer Research UK London.
Epidemiology October 21, 2014 II. Morbidity and Mortality.
Extending the Gail model for Breast Cancer Risk Prediction to Account for Modifiable Factors in the Italian Population. Calza S, Ferraroni M, Decarli A.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2014.
Epidemiology of breast cancer Rulla Tamimi, ScD Associate Professor of Medicine Harvard Medical School.
Citations Source: BRFSS, CDC. Source: Mokdad A H, et al. JAMA 1999;282:16. Source: Mokdad A H, et al. JAMA 2001;286:10. Source: Mokdad A H, et al. JAMA.
Criteria for Assessment of Performance of Cancer Risk Prediction Models: Overview Ruth Pfeiffer Cancer Risk Prediction Workshop, May 21, 2004 Division.
First month Second Month First month Second Month Milk line remnant Milk line remnant Accessory axillary breast tissue Accessory axillary breast tissue.
Biostatistics Case Studies 2005 Peter D. Christenson Biostatistician Session 4: Taking Risks and Playing the Odds: OR vs.
Coffee Consumption and Risk of Myocardial Infarction among Older Swedish Women SA Rosner, A Akesson,MJ. Stampfer, A Wolk; AJE; :
CASE: BREAST CANCER Alegre. Almora. Alonzo. Amaro. Amolenda. Anacta. Andal. Ang. Ang. Ang.
Metabolic Syndrome and Recurrence within the 21-Gene Recurrence Score Assay Risk Categories in Lymph Node Negative Breast Cancer Lakhani A et al. Proc.
Alcohol and Ovarian Cancer Publication Genkinger, JM, et al.. Br J Cancer 2006 Mar 13;94(5): Genkinger, JM, et al. Alcohol intake and ovarian cancer.
March 10, 2014 NURS 330 Human Reproductive Health.
Personal Risk Factors Gender being a woman is the main risk factor for developing breast cancer (100 times more common in women) Age occurrence increase.
HEALTH PSYCHOLOGY Psychological Aspects of Breast Cancer.
MBP1010 – Lecture 8: March 1, Odds Ratio/Relative Risk Logistic Regression Survival Analysis Reading: papers on OR and survival analysis (Resources)
How to Calculate Your Body Mass Index (BMI)
Breast Cancer in the Women’s Health Initiative Trial of Estrogen Plus Progestin For the WHI Investigators Rowan T Chlebowski, MD., Ph.D.
Breast Cancer Prevention Art or Science? Kristi McIntyre M.D. Texas Oncology 2005.
Obesity Trends Among U.S. Adults between 1985 and 2003 Source of the data: The data shown in these maps were collected through CDC’s Behavioral Risk Factor.
Citations Source: BRFSS, CDC. Source: Mokdad A H, et al. JAMA 1999;282:16. Source: Mokdad A H, et al. JAMA 2001;286:10. Source: Mokdad A H, et al. JAMA.
Identifying Overweight A short presentation to assist in identifying when to seek help.
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
Breast Cancer Surveillance Consortium (BCSC): A Research Infrastructure sponsored by the National Cancer Institute Breast Cancer Risk Models William Barlow,
Healthy Weight for Teens Body Mass Index (BMI) & Basal Metabolic Rate (BMR)
Date of download: 5/31/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Estrogen Plus Progestin and Breast Cancer Incidence.
Date of download: 5/31/2016 From: Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years: A Comparative Modeling.
Chapter 11 Where Do Data Come From?. Statistics: Concepts and Controversies.
Date of download: 6/29/2016 From: Long-Term Health Outcomes in Women With Silicone Gel Breast Implants: A Systematic Review Ann Intern Med. 2016;164(3):
Date of download: 6/29/2016 From: Overdiagnosis of Invasive Breast Cancer Due to Mammography Screening: Results From the Norwegian Screening Program Ann.
Prediction of lung cancer mortality in Central & Eastern Europe Joanna Didkowska.
Understanding weight gain at menopause
Epidemiologic Measures of Association
Endometrial cancer on the rise in older women (August 2014)
Breast cancer: patterns and risk factors in older and younger women (June 2014) Breast cancer incidence is low in women under the age of 50 and has remained.
Weight Loss and Breast Cancer Incidence in Postmenopausal Women
Bronx Community Health Dashboard: Breast Cancer Last Updated: 1/19/2018 See last slide for more information about this project. While breast.
Breast Health Katherine B. Lee, MD, FACP April 26, 2018.
BMI: Body Mass Index.
Presenter: Wen-Ching Lan
Bergh J et al. SABCS 2009;Abstract 23.
Volume 11, Issue 6, Pages (June 2010)
Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: First-line Considerations.
Volume 16, Issue 9, Pages (September 2015)
Volume 13, Issue 11, Pages (November 2012)
Bernard Rosner Channing Division of Network Medicine
Nadia Howlader, PhD National Cancer Institute
Risk (aOR) of breast cancer associated with the combination of putative at-risk genotypes of the MRN genes and the reproductive risk factors of a history.
Presentation transcript:

1 Breast Cancer Risk Prediction Bernard Rosner Impact of Time-Dependent Risk Factors and Heterogeneity by ER/PR Receptor Status

2 I. Nature of Risk Prediction 1.Breast cancer is a complex disease that has many risk factors. 2.The nature of the risk factors and their magnitude of effect changes over time. 3.We’ve chosen to quantify the effects of each risk factor by developing a calendar over time for that risk factor from menarche to pre-menopause to post-menopause and summarizing effects over the calendar (e.g., average BMI before menopause; average BMI after menopause)

3 II. Metrics of Risk (annual incidence vs. cumulative incidence) ANNUAL INCIDENCE Most risk prediction algorithms are based on (annual) incidence (I.e. short-term risk) – e.g., 50 year old women – what is the risk of breast cancer over the next year However, annual incidence is usually low and of perhaps more relevance is cumulative incidence over longer periods of time (e.g. age 50 to age 70)

4 II. Metrics of Risk (annual incidence vs. cumulative incidence) CUMULATIVE INCIDENCE 1. Cumulative incidence A)Requires a Kaplan-Meier type calculation B)If risk factors change over time (which is likely for BMI, PMH use and possible BBD and family Hx as well) then cumulative incidence will change as a function of these variables 2.Risk prediction in terms of cumulative incidence is not simply a single estimate of risk but rather a collection of possible risks, according to possible changes in risk factor status (perhaps over long periods of time)

5 III. Age-specific and cumulative incidence of breast cancer by weight profile, Nurses’ Health Study, Weight percentile Cumulative incidence age (x10 -5 ) 18 years50 years60 tears70 years %BMI% % % RR Average woman (ref) Stable weight Above average weight gain Consistently lean Consistently obese AJE 2000 (10)152: Age at menarche=13 years; parity=2; ages at birth=20 and 23 years; age at menopause=50 years; type of menopause=natural; no postmenopausal hormone therapy; women with no benign breast disease, no family history, average height (I.e., height before menopause= 64.5 inches (163.8 cm); height after menopause= 64.4 inches (163.6 cm), lifetime nondrinkers.

6 IV. Breast cancer subtypes 1.Virtually all risk prediction for breast cancer assumes that breast cancer is a homogeneous disease, i.e. all types of breast cancer have the same risk profiles 2.Recent work (Colditz et al, JNCI 2004) has indicated that risk factor profiles may vary according to both ER status and PR status for some risk factors, but are the same for other risk factors

7 Risk factorER+/PR+ER-/PR- AgeDuration of premenopause 11%/yr p<.0015%/yr p=0.001 Duration of natural menopause 5%/yr p<.0011%/yr p=0.13 RR (95% CI) Age at menopause ( )1.24 ( ) Pregnancy HistoryNulliparous1.0 20,23,26, ( )1.07 ( ) ( )1.39 ( ) PMH use (10 yrs)Estrogen1.18 ( )0.96 ( ) Estrogen + progesterone 1.67 ( )1.21 ( ) 3.

8 Risk factorER+/PR+ER-/PR- RR (95% CI) Body Mass IndexAvg. woman*1.0 Above avg. wt.gain Woman ( )0.96 ( ) BBDNo1.0 Yes1.64 ( )1.54 ( ) Family Hx of breast cancer No1.0 Yes1.45 ( )1.70 ( ) 3. (con’t) * 50 percentile at age 18 (123 lbs), 50 (142 lbs), 60 (146 lbs), 70 (145 lbs) + 50 percentile at age 18 (123 lbs), 90 percentile at age 50 (185 lbs), 60 (190 lbs), 70 (185 lbs)

9 V. Implications of heterogeneity of risk for breast cancer subtypes on risk prediction 1.Different risk model for breast cancer-specific subtypes (e.g. ER+/PR+, ER-/PR-) 2.Risk model for total breast cancer is no longer a simple Poisson regression model, but is instead a mixture of different risk models for different disease subtypes 3.A polychotomous logistic regression (PLR) model is required to fit the data. 4.One implication of this model is that some properties of Poisson regression – e.g. constant relative risk over the full range of risk factor X are no longer valid

10 5. Instead, a risk surface has to be developed based on specified combinations of risk factors: V. Implications of heterogeneity of risk for breast cancer subtypes on risk prediction Age at menarche Age at menopause Parity AAfB BBD Family Hx Anthropometric variables PMH use Etc.

11 Summary 1.Breast cancer is a complex disease with many possibly time dependent risk factors 2.Short-term risk prediction involves current and past levels of risk factors 3.Long-term risk prediction is also determined by how risk factors will change prospectively and may involve more than a single estimate of risk 4.Risk factor profiles for different types of breast cancer may vary according to ER/PR status 5.Short-term absolute risk is low; relative risk between age- specific extreme deciles is 5-7 fold for ER+/PR+ breast cancer; 4 fold for ER-/PR- breast cancer, making risk stratification viable at least on a group level.